The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response and the Department of Defense’s Defense Threat Reduction Agency will provide funding to VenatoRx Pharmaceuticals to develop a novel antibiotic to treat infections resistant to existing antibiotics. ASPR’s Biomedical Advanced Research and Development Authority will initially provide up to $20.7 million to help develop the product and conduct clinical trials, including trials to treat hospital-acquired and ventilator-associated bacterial pneumonia and carbapenem-resistant pathogens. DTRA will provide up to $10 million to test the product against antibiotic-resistant bioterrorism pathogens. “Developing new antibiotics that represent an improvement over standard of care antibiotics is essential to national health security and global health efforts to combat antibiotic-resistant infections,” said BARDA Director Rick Bright. “This unique public-private partnership will focus on adding a new tool to health care providers’ toolkits and to help them save lives in an incident involving some of the serious bioterrorism threats our country faces.”
 

Related News Articles

Headline
The Centers for Disease Control and Prevention today updated its Core Elements for Hospital Antibiotic Stewardship Programs to reflect experience and evidence…
Headline
Antibiotic-resistant bacteria and fungi cause more than 2.8 million infections and 35,000 deaths in the United States each year, according to a report released…
Headline
The Department of Health and Human Services and Centers for Disease Control and Prevention last night celebrated nearly 350 organizations, including the AHA,…
Headline
The Food and Drug Administration yesterday approved a new antibiotic to treat adults with community-acquired bacterial pneumonia. The antibiotic, Xenleta…
Headline
The number of U.S. hospitals with an antibiotic stewardship program that meets all core elements recommended by the Centers for Disease Control and Prevention…
Headline
In a commentary published in Academic Medicine, experts from the AHA, Centers for Disease Control and Prevention, Federal Office of Rural Health Policy and Pew…